Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabienne Lucas

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Research and Practice in Thrombosis and Haemostasis|October 14, 2021
Rivaroxaban-calibrated chromogenic anti-Xa assay in cirrhosis: Use to rule out disseminated intravascular coagulationFabienne Lucas, Michael S Stecker, Olga Pozdnyakova, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|November 27, 2019
MiSet RFC Standards: Defining a Universal Minimum Set of Standards Required for Reproducibility and Rigor in Research Flow Cytometry ExperimentsFabienne Lucas, Jesus Gil-Pulido, John LaMacchia, et al.
Cytometry. Part B, Clinical Cytometry|February 26, 2024
Recommendations for using artificial intelligence in clinical flow cytometryDavid P Ng, Paul D Simonson, Attila Tarnok, et al.
American Journal of Clinical Pathology|August 7, 2023
One-year retrospective analysis of anti-FXa apixaban and rivaroxaban levels demonstrates utility for management decisions in various urgent and nonurgent clinical situationsFabienne Lucas, Joshua Lewis, Jessica Grandoni, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 25, 2019
T Cell Transcriptional Profiling and Immunophenotyping Uncover LAG3 as a Potential Significant Target of Immune Modulation in Multiple MyelomaFabienne Lucas, Michael Pennell, Ying Huang, et al.
Haematologica|January 13, 2018
Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogoninClaudia Dürr, Bola S Hanna, Angela Schulz, et al.
Scientific Reports|February 12, 2021
Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networksTimothy H Helms, Riley D Mullins, Jennifer M Thomas-Ahner, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
DeepHeme: A generalizable, bone marrow classifier with hematopathologist-level performanceGregory M Goldgof, Shenghuan Sun, Jacob Van Cleave, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 4, 2024
Acute Promyelocytic Leukemia With Torque Teno Mini Virus::RARA Fusion: An Approach to Screening and DiagnosisHarrison K Tsai, Mark F Sabbagh, Meagan Montesion, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2019
Eμ-TCL1xMyc: A Novel Mouse Model for Concurrent CLL and B-Cell LymphomaFabienne Lucas, Kerry A Rogers, Bonnie K Harrington, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Research and Practice in Thrombosis and Haemostasis|October 14, 2021
Rivaroxaban-calibrated chromogenic anti-Xa assay in cirrhosis: Use to rule out disseminated intravascular coagulationFabienne Lucas, Michael S Stecker, Olga Pozdnyakova, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|November 27, 2019
MiSet RFC Standards: Defining a Universal Minimum Set of Standards Required for Reproducibility and Rigor in Research Flow Cytometry ExperimentsFabienne Lucas, Jesus Gil-Pulido, John LaMacchia, et al.
Cytometry. Part B, Clinical Cytometry|February 26, 2024
Recommendations for using artificial intelligence in clinical flow cytometryDavid P Ng, Paul D Simonson, Attila Tarnok, et al.
American Journal of Clinical Pathology|August 7, 2023
One-year retrospective analysis of anti-FXa apixaban and rivaroxaban levels demonstrates utility for management decisions in various urgent and nonurgent clinical situationsFabienne Lucas, Joshua Lewis, Jessica Grandoni, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 25, 2019
T Cell Transcriptional Profiling and Immunophenotyping Uncover LAG3 as a Potential Significant Target of Immune Modulation in Multiple MyelomaFabienne Lucas, Michael Pennell, Ying Huang, et al.
Haematologica|January 13, 2018
Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogoninClaudia Dürr, Bola S Hanna, Angela Schulz, et al.
Scientific Reports|February 12, 2021
Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networksTimothy H Helms, Riley D Mullins, Jennifer M Thomas-Ahner, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
DeepHeme: A generalizable, bone marrow classifier with hematopathologist-level performanceGregory M Goldgof, Shenghuan Sun, Jacob Van Cleave, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 4, 2024
Acute Promyelocytic Leukemia With Torque Teno Mini Virus::RARA Fusion: An Approach to Screening and DiagnosisHarrison K Tsai, Mark F Sabbagh, Meagan Montesion, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2019
Eμ-TCL1xMyc: A Novel Mouse Model for Concurrent CLL and B-Cell LymphomaFabienne Lucas, Kerry A Rogers, Bonnie K Harrington, et al.
Pageof 3